Manufacture

Manufacture Advanced Medicine

04/12/2023 | Rob Coker | 5 min read

Oligonucleotides are a complex but promising new modality in therapeutics. Director of New Modalities at CatSci Nigel Richardson explains why.

Manufacture Bioprocessing - Upstream & Downstream

04/05/2023 | Nandu Deorkar, Jungmin Oh, Pranav Vengsarkar, Jonathan Fura | 6 min read

From resins to buffers to single-use technologies – there are many opportunities to improve downstream processes.

Manufacture Facilities

04/04/2023 | Grant Merrill | 3 min read

Why modular designs will be the future of advanced therapy manufacturing.

Manufacture Bioprocessing - Upstream & Downstream

04/04/2023 | Adam Pinkert, Áine Brennan | 6 min read

How the thoughtful adoption of new technology can both problem-solve and future- proof critical processes in biomanufacturing

Manufacture Advanced Medicine

03/29/2023 | Rob Coker | 4 min read

CellProthera is demonstrating the safety and efficacy of a cell therapy approach to regenerating tissue following myocardial infarction

Manufacture Vaccines

03/16/2023 | Stephanie Vine | 7 min read

Universal flu vaccines have been the holy grail for many years – are we onto a breakthrough at last?

Manufacture Technology and Equipment

03/15/2023 | Sponsored by KNAUER | 3 min read

Looking for an adaptable screening approach for lipid nanoparticle R&D?

Manufacture Advanced Medicine

03/08/2023 | Stephanie Vine | 2 min read

Libmeldy gene therapy is used for the first time in the UK outside of a clinical trial.

Manufacture Bioprocessing - Upstream & Downstream

03/07/2023 | Stephanie Vine

A video interview discussing the challenges of viral vectors

Manufacture Small Molecules

03/02/2023 | Charles Johnson | 4 min read

Pipelines are changing, and chemical complexity is on the rise. What can pharma manufacturers do about it?